72 related articles for article (PubMed ID: 205846)
21. Are increases in cyclic GMP levels responsible for the negative inotropic effects of acetylcholine in the heart?
Diamond J; Ten Eick RE; Trapani AJ
Biochem Biophys Res Commun; 1977 Dec; 79(3):912-8. PubMed ID: 202278
[No Abstract] [Full Text] [Related]
22. [Does non-quantum secretion of acetylcholine from motor neuron endings participate in the neurotrophic control of the membrane potential of muscle fibers in the rat?].
Volkov EM; Frosin VN; Poletaev GI
Neirofiziologiia; 1985; 17(3):358-65. PubMed ID: 2991787
[TBL] [Abstract][Full Text] [Related]
23. [Independence of the insulin effect from the guanosine-3',5'-monophosphate level in muscle tissue].
Kudriavtseva NV; Vinogradova NA; Novikov IP; Nikol'skiĭ NN
Tsitologiia; 1981 Dec; 23(12):1403-10. PubMed ID: 6277062
[TBL] [Abstract][Full Text] [Related]
24. [Modification of inotropic vagus action by stretching of the heart atrium].
Nilius B
Acta Biol Med Ger; 1980; 39(4):403-14. PubMed ID: 7445890
[TBL] [Abstract][Full Text] [Related]
25. Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction.
Zhang Q; Scholz PM; He Y; Tse J; Weiss HR
Cell Calcium; 2005 Mar; 37(3):259-66. PubMed ID: 15670873
[TBL] [Abstract][Full Text] [Related]
26. Do the intracellular beta adrenoreceptors exist in the rabbit auricle.
Tuganowski W; Kopeć P; Kaszuba M; Glanc A
Pol J Pharmacol Pharm; 1981; 33(1):49-52. PubMed ID: 6265892
[TBL] [Abstract][Full Text] [Related]
27. Cholinergic agonists and dibutyryl cyclic guanosine monophosphate inhibit the norepinephrine-induced accumulation of cyclic adenosine monophosphate in the rat cerebral cortex.
Palmer GC; Chronister RB; Palmer SJ
Neuroscience; 1980; 5(2):319-22. PubMed ID: 6246467
[No Abstract] [Full Text] [Related]
28. Muscarinic and cGMP induced membrane potential changes: differences in electrogenic mechanisms.
Dun NJ; Kaibara K; Karczmar AG
Brain Res; 1978 Jul; 150(3):658-61. PubMed ID: 209855
[No Abstract] [Full Text] [Related]
29. Altered role of C-type natriuretic peptide-activated pGC-cGMP-PDE3-cAMP signaling in hyperthyroid beating rabbit atria.
Wen JF; Quan HX; Zhou GH; Cho KW
Regul Pept; 2007 Aug; 142(3):123-30. PubMed ID: 17531330
[TBL] [Abstract][Full Text] [Related]
30. Effects of the cyclic GMP lowering agent LY83583 on the interaction of carbachol with forskolin in rabbit isolated cardiac preparations.
MacLeod KM; Diamond J
J Pharmacol Exp Ther; 1986 Jul; 238(1):313-8. PubMed ID: 3014120
[TBL] [Abstract][Full Text] [Related]
31. Cyclic nucleotides and haemoglobin concentration in rabbit bone marrow cell suspensions stimulated by purified erythropoietin.
Fanò G; Della Torre G; Menchetti G; Secca T; Marsili V
Cell Biochem Funct; 1984 Apr; 2(2):119-24. PubMed ID: 6088113
[TBL] [Abstract][Full Text] [Related]
32. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
[TBL] [Abstract][Full Text] [Related]
33. Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells.
Hartzell HC; Fischmeister R
Nature; 1986 Sep 18-24; 323(6085):273-5. PubMed ID: 2429189
[TBL] [Abstract][Full Text] [Related]
34. [Effect of a new beta-blocker (CM 6805) on the action potential of guinea pig atrial fiber].
Re GG; Eandi M; Molinaris F; Taglia P
Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1264-70. PubMed ID: 6109540
[TBL] [Abstract][Full Text] [Related]
35. Elevated cyclic GMP levels in rabbit atria following vagal stimulation and acetylcholine treatment.
Fink GD; Paddock RJ; Rodgers GM; Busuttil RW; George WJ
Proc Soc Exp Biol Med; 1976 Oct; 153(1):78-82. PubMed ID: 186802
[No Abstract] [Full Text] [Related]
36. Dibutyryl cyclic GMP and hyperventilation promote rat lung phospholipid release.
Klass DJ
J Appl Physiol Respir Environ Exerc Physiol; 1979 Aug; 47(2):285-9. PubMed ID: 224023
[TBL] [Abstract][Full Text] [Related]
37. [Effect of cyclic nucleotides on the sensitivity of early sea urchin embryos to cytotoxic neuropharmacological preparations].
Shmukler IuB; Buznikov GA; Grigor'ev NG; Mal'chenko LA
Biull Eksp Biol Med; 1984 Mar; 97(3):354-5. PubMed ID: 6322883
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of cholecystokinin receptors in rat pancreatic membranes by sulfhydryl reagents: protection by guanosine 5'-triphosphate (GTP) but not N2,O2-dibutyryl guanosine 3',5'-cyclic monophosphate (dibutyryl cGMP).
Chang RS; Lotti VJ; Chen TB
Biochem Pharmacol; 1984 Jul; 33(14):2334-5. PubMed ID: 6087823
[No Abstract] [Full Text] [Related]
39. Cyclic GMP and protein kinase G inhibit the quantal transmitter release induced by protein kinase C.
Brănişteanu DD; Popescu LM; Brănişteanu DD; Haulică ID
Brain Res; 1988 Nov; 464(3):263-6. PubMed ID: 2850086
[TBL] [Abstract][Full Text] [Related]
40. Does cyclic GMP mediate the negative inotropic effect of acetylcholine in the heart?
Nawrath H
Nature; 1977 May; 267(5606):72-4. PubMed ID: 193045
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
